{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:40:55Z","timestamp":1747168855447,"version":"3.40.5"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.parkreldis.2023.105889","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T15:43:38Z","timestamp":1697039018000},"page":"105889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A new phenotype of myorhythmia: Oculofacial myorhythmia in a patient with Erdheim Chester disease"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0342-0177","authenticated-orcid":false,"given":"Gary","family":"\u00c1lvarez-Bravo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.parkreldis.2023.105889_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/acn3.51014","article-title":"Neurological manifestations of erdheim-chester disease","volume":"7","author":"Boyd","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105889_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF01942684","article-title":"\u00fcber Lipoid granulomatose","volume":"279","author":"Chester","year":"1930","journal-title":"Virchows Arch Path. Anat."},{"key":"10.1016\/j.parkreldis.2023.105889_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.parkreldis.2023.105889_bib4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2016-09-740217","article-title":"Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations","volume":"129","author":"Nordmann","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.parkreldis.2023.105889_bib5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.2003.035584","article-title":"Treatment of Erdheim-Chester disease with cladribine: a rational approach","volume":"88","author":"Myra","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.parkreldis.2023.105889_bib6","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2010-04-279240","article-title":"Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease","volume":"116","author":"Aouba","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.parkreldis.2023.105889_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","article-title":"Erdheim\u2010Chester disease: a systematic review","volume":"95","author":"Cives","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.parkreldis.2023.105889_bib8","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","article-title":"CNS involvement and treatment with interferon\u2010alpha are independent prognostic factors in Erdheim\u2010Chester Disease: a multicenter survival analysis of 53 patients","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.parkreldis.2023.105889_bib9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/mdc3.13343","article-title":"Oculomasticatory myorhythmia, an underrecognized yet key finding for the topographic and etiological diagnosis in patients with rhombencephalitis. Videographic record of a case","volume":"8","author":"L\u00f3pez Dom\u00ednguez","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105889_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Tremor task force of the international Parkinson and movement disorder society. Consensus statement on the classification of tremors. From the task force on tremor of the international Parkinson and movement disorder society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105889_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mds.26093","article-title":"Myorhythmia: phenomenology, etiology, and treatment","volume":"30","author":"Baizabal-Carvallo","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105889_bib12","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.clinph.2010.04.034","article-title":"Electro- physiological assessment of a case of limb myorhythmia","volume":"121","author":"van Meerbeeck","year":"2010","journal-title":"Clin. Neurophysiol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T02:13:56Z","timestamp":1716171236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023009689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":12,"alternative-id":["S1353802023009689"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105889","relation":{},"ISSN":["1353-8020"],"issn-type":[{"type":"print","value":"1353-8020"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new phenotype of myorhythmia: Oculofacial myorhythmia in a patient with Erdheim Chester disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105889"}}